The Ohio State University Dermatology Biorepository
ConditionHidradenitis Suppurativa
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorOhio State University
About this trial
This study will create and extend a source of clinical specimens for the future study of inflammatory skin disorders.
Eligibility criteria
Qualifiers
Seen by an Ohio State University (OSU) Dermatology provider on the main University Hospital campus, including the James Cancer Hospital, OSU Dermatology East, OSU Dermatology at the Ohio State Eye and Ear Institute, Martha Morehouse Medical Pavilion, and OSU Dermatology at Upper Arlington after the date of approval of this protocol
Ability to provide informed consent, or parent or legal guardian capable of providing consent for child or mentally handicapped individuals
Willingness to participate in a research study.
Disqualifiers
Inability to provide informed consent
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov